COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 4 of 4 for:    AKCEA-ANGPTL3-Lrx

Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03371355
Recruitment Status : Completed
First Posted : December 13, 2017
Last Update Posted : March 13, 2020
Ionis Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Akcea Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 21, 2019
Actual Study Completion Date : February 24, 2020